Related references
Note: Only part of the references are listed.Interaction of cardiac troponin with cardiotonic drugs: A structural perspective
Monica X. Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I
Olga K. Baryshnikova et al.
BIOCHEMISTRY (2008)
Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
Challenging Current Paradigms Related to Cardiomyopathies ARE CHANGES IN THE Ca2+ SENSITIVITY OF MYOFILAMENTS CONTAINING CARDIAC TROPONIN C MUTATIONS (G159D AND L29Q) GOOD PREDICTORS OF THE PHENOTYPIC OUTCOMES?
David Dweck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Differential effects of a green tea-derived polyphenol (-)-epigallocatechin-3-gallate on the acidosis-induced decrease in the Ca2+ sensitivity of cardiac and skeletal muscle
Ying-Ming Liou et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
Timothy A. McKinsey et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Positive inotropic effect of purified green tea catechin derivative in guinea pig hearts:: The measurements of cellular Ca2+ and nitric oxide release
Yoshihiro Hotta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Interaction of cardiac troponin C and troponin I with W7 in the presence of three functional regions of cardiac troponin I
Monica X. Li et al.
BIOCHEMISTRY (2006)
Structure and intramolecular flexibility of β-cyclodextrin complex with (-)-epigallocatechin gallate in aqueous solvent
Takashi Ishizu et al.
MAGNETIC RESONANCE IN CHEMISTRY (2006)
Mechanisms and use of calcium-sensitizing agents in the failing heart
DA Kass et al.
CIRCULATION (2006)
Pathophysiology and treatment of hypertrophic cardiomyopathy
Mark V. Sherrid
PROGRESS IN CARDIOVASCULAR DISEASES (2006)
The bindin of W7, an inhibitor of striated muscle contraction, to cardiac troponin C
RMB Hoffman et al.
BIOCHEMISTRY (2005)
Ca2+-regulated structural changes in troponin
MV Vinogradova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The evolving role of natural products in drug discovery
FE Koehn et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Biology of the troponin complex in cardiac myocytes
MS Parmacek et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2004)
Interplay of troponin- and myosin-based pathways of calcium activation in skeletal and cardiac muscle: The use of W7 as an inhibitor of thin filament activation
BB Adhikari et al.
BIOPHYSICAL JOURNAL (2004)
Structural based insights into the role of troponin in cardiac muscle pathophysiology
MX Li et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2004)
Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides
T Sorsa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Structure and dynamics of the C-domain of human cardiac troponin C in complex with the inhibitory region of human cardiac troponin I
DA Lindhout et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Structure of the core domain of human cardiac troponin in the Ca2+-saturated form
S Takeda et al.
NATURE (2003)
Smartnotebook: A semi-automated approach to protein sequential NMR resonance assignments
CM Slupsky et al.
JOURNAL OF BIOMOLECULAR NMR (2003)
The role of troponins in muscle contraction
AV Gomes et al.
IUBMB LIFE (2002)
Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA
T Herrmann et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Hypertrophic cardiomyopathy - A systematic review
BJ Maron
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Mechanism of action of Ca2+ sensitizers -: Update 2001
M Endoh
CARDIOVASCULAR DRUGS AND THERAPY (2001)
The molecular interaction of human salivary histatins with polyphenolic compounds
K Wróblewski et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Structure of the C-domain of human cardiac troponin C in complex with the Ca2+ sensitizing drug EMD 57033
X Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms
JG Seidman et al.
CELL (2001)
Epicatechin and catechin are O-methylated and glucuronidated in the small intestine
G Kuhnle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Interaction of cardiac troponin C with Ca2+ sensitizer EMD 57033 and cardiac troponin I inhibitory peptide
MX Li et al.
BIOCHEMISTRY (2000)
Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: Reliable reduction with tris[2-carboxyethyl] phosphine hydrochloride
J Lykkesfeldt
ANALYTICAL BIOCHEMISTRY (2000)
Role of the structural domain of troponin C in muscle regulation:: NMR studies of Ca2+ binding and subsequent interactions with regions 1-40 and 96-115 of troponin I
P Mercier et al.
BIOCHEMISTRY (2000)
Share Paper
